Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Multiple myeloma: is it time for biomarker-driven therapy?
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multiple myeloma: is it time for biomarker-driven therapy?
Bhutani M, Landgren O, Usmani SZ. Multiple myeloma: is it time for biomarker-driven therapy? Am Soc Clin Oncol Educ Book. 2015; e493-503.
View in:
PubMed
subject areas
Biomarkers, Tumor
Bone Remodeling
Clinical Trials as Topic
Cytogenetics
Disease Progression
Epigenesis, Genetic
Flow Cytometry
Gene Expression Profiling
Genetic Markers
Humans
In Situ Hybridization, Fluorescence
Multiple Myeloma
Myeloma Proteins
Neoplasm Staging
Neoplasm, Residual
Positron-Emission Tomography
Tomography, X-Ray Computed
authors with profiles
Saad Usmani MD